NOCERA INC (NCRA)

US6551865008 - Common Stock

0.864  -0.13 (-13.26%)

After market: 0.864 0 (0%)

Fundamental Rating

2

Overall NCRA gets a fundamental rating of 2 out of 10. We evaluated NCRA against 45 industry peers in the Construction & Engineering industry. The financial health of NCRA is average, but there are quite some concerns on its profitability. While showing a medium growth rate, NCRA is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

In the past year NCRA has reported negative net income.
NCRA had a negative operating cash flow in the past year.
In the past 5 years NCRA reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: NCRA reported negative operating cash flow in multiple years.

1.2 Ratios

NCRA has a worse Return On Assets (-57.06%) than 95.45% of its industry peers.
Looking at the Return On Equity, with a value of -75.70%, NCRA is doing worse than 88.64% of the companies in the same industry.
Industry RankSector Rank
ROA -57.06%
ROE -75.7%
ROIC N/A
ROA(3y)-70.64%
ROA(5y)-41.44%
ROE(3y)-102.01%
ROE(5y)-76.37%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 1.18%, NCRA is doing worse than 88.64% of the companies in the same industry.
In the last couple of years the Gross Margin of NCRA has declined.
NCRA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-72.1%
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

NCRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NCRA has less shares outstanding
Compared to 5 years ago, NCRA has less shares outstanding
The debt/assets ratio for NCRA is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 3.02 indicates that NCRA is not in any danger for bankruptcy at the moment.
NCRA has a Altman-Z score (3.02) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.06 indicates that NCRA is not too dependend on debt financing.
NCRA has a better Debt to Equity ratio (0.06) than 84.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 3.02
ROIC/WACCN/A
WACC10.6%

2.3 Liquidity

A Current Ratio of 1.37 indicates that NCRA should not have too much problems paying its short term obligations.
The Current ratio of NCRA (1.37) is comparable to the rest of the industry.
NCRA has a Quick Ratio of 1.31. This is a normal value and indicates that NCRA is financially healthy and should not expect problems in meeting its short term obligations.
NCRA has a Quick ratio of 1.31. This is comparable to the rest of the industry: NCRA outperforms 47.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.31

4

3. Growth

3.1 Past

NCRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.13%, which is quite impressive.
Looking at the last year, NCRA shows a very strong growth in Revenue. The Revenue has grown by 94.19%.
Measured over the past years, NCRA shows a very strong growth in Revenue. The Revenue has been growing by 228.72% on average per year.
EPS 1Y (TTM)64.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.04%
Revenue 1Y (TTM)94.19%
Revenue growth 3Y228.72%
Revenue growth 5YN/A
Sales Q2Q%431.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

NCRA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NCRA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NOCERA INC

NASDAQ:NCRA (12/27/2024, 8:00:01 PM)

After market: 0.864 0 (0%)

0.864

-0.13 (-13.26%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)08-21 2023-08-21/amc
Earnings (Next)N/A N/A
Inst Owners0.73%
Inst Owner Change-11.06%
Ins Owners18.25%
Ins Owner Change0.46%
Market Cap12.11M
AnalystsN/A
Price TargetN/A
Short Float %0.1%
Short Ratio0.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.46
P/FCF N/A
P/OCF N/A
P/B 2.12
P/tB 7.17
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS1.88
BVpS0.41
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -57.06%
ROE -75.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.18%
FCFM N/A
ROA(3y)-70.64%
ROA(5y)-41.44%
ROE(3y)-102.01%
ROE(5y)-76.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-72.1%
GM growth 5YN/A
F-Score4
Asset Turnover3.47
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.3%
Cap/Sales 0.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 1.31
Altman-Z 3.02
F-Score4
WACC10.6%
ROIC/WACCN/A
Cap/Depr(3y)125%
Cap/Depr(5y)372.78%
Cap/Sales(3y)2.66%
Cap/Sales(5y)32.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)94.19%
Revenue growth 3Y228.72%
Revenue growth 5YN/A
Sales Q2Q%431.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y57.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1458.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-948.92%
OCF growth 3YN/A
OCF growth 5YN/A